FAM-FLICA Caspase 8 Assay Kit | FAM-FLICA assay kit

FAM-FLICA Caspase 8 Assay Kit

Cat. Num. AAA258011

• Synonyms: FAM-FLICA Caspase 8; FAM-FLICA Caspase 8 Assay Kit; FAM-FLICA assay kit

• Assay Type: Sandwich
• Preparation and Storage: Store at 2-8 degree C

Testing Data

(ICT's Caspase 8 FLICA kit was used todetect apoptosis in U937 cells, ahistiocytic lymphoma cell line. Cells weretreated with a control, 50 ng/mL TNF, or50 ug/mL cycloheximide (CHX) for 24hours. Cells were then incubated withFAM-LETD-FMK for 1 hour, washed 4times, then analyzed on a flowcytometer. FLICA revealed that 41.9%of cells treated with CHX had caspase 8 activity, compared with 19.1% of cellstreated with TNF, and only 1.9% of the control cells (Ms. Jennifer Mitchell,Scripps).)

Related Product Information for FAM-FLICA assay kit

Background/Introduction: FLICA® is a powerful method to assess cell death by detecting apoptosis in vitro. ????????????probes are non-cytotoxic Fluorescent Labeled Inhibitors of CAspases that covalently bind to active caspase enzymes1,2. FLICA measures the intracellular process of apoptosis instead of a sideeffect, such as the turn-over of phosphatidyl serine, and eliminates the incidence of false positives that often plagues methods like Annexin V and TUNEL staining. FLICA can also be used to measure pyroptosis, a highly inflammatory form of programmed cell death. To use FLICA, add it directly to the cell culture media, incubate, and wash. FLICA is cell-permeant and will efficiently diffuse in and out of all cells. If there is an active caspase enzyme inside the cell, it will covalently bind with FLICA and retain the green fluorescent signal within the cell. Unbound FLICA will diffuse out of the cell during the wash steps. Apoptotic and pyroptotic cells will retain a higher concentration of FLICA and fluoresce brighter than healthy cells. There is no interference from pro-caspases or inactive forms of the enzymes. If the treatment is causing cell death via apoptosis and/or pyroptosis, the cells will contain an elevated level of caspase activity relative to negative control cells and fluoresce with FLICA. Apoptosis is an evolutionarily conserved process of programmed cell suicide. It is centered on a cascade of proteolytic enzymes called caspases that are triggered in response to pro-apoptotic signals. Once activated, caspases cleave protein substrates leading to the eventual disassembly of the cell3. Caspases have been identified in organisms ranging from C. elegans to humans. Mammalian caspases play distinct roles in both apoptosis and inflammation. In apoptosis, effector caspases (-3, -6, and -7) are responsible for proteolytic cleavages that lead to cell disassembly. Initiator caspases (-8, -9, and -10) regulate apoptosis upstream. Caspase-1 is associated with pyroptosis and inflammasome activity and takes on the role of a key housekeeping enzyme in its conversion of pro-IL-1beta protein into the active IL-1beta cytokine. (Use FLICA kits to detect caspase-1.) Please note that macrophages and monocytes have been shown to rapidly secrete caspase-1 upon activation4,5. Like the majority of other proteases, caspases are synthesized as pro-form precursors that undergo proteolytic maturation, either autocatalytically or in a cascade by enzymes with similar specificity6. Active caspase enzymes consist of two large (~20 kD) and two small (~10 kD) subunits that non-covalently associate to form a two heterodimer, tetrameric active caspase7-9. Activated caspase enzymes cleave proteins by recognizing a 3 or 4 amino acid sequence that must include an aspartic acid (D) residue in the P1 position. This C-terminal residue is the target for the cleavage reaction at the carbonyl end10. Each FLICA probe contains a 3 or 4 amino acid sequence that is targeted by different activated caspases. This target sequence is sandwiched between a green fluorescent label, carboxyfluorescein (FAM), and a fluoromethyl ketone (FMK). A caspase enzyme cannot cleave the FLICA inhibitor probe; instead, it forms an irreversible covalent bond with the FMK on the target sequence and becomes inhibited from further enzymatic activity. ??oly caspase FLICA probe, FAM-VAD-FMK, can be used as a general reagent to detect apoptosis as it is recognized by many types of activated caspases. To more specifically target a particular caspase enzyme, use one of specialized FLICA reagents. ???? ha??????kits for the detection of: caspase-1 (YVAD or WEHD) (also recognizes caspases 4 and 5), -2 (VDVAD), -3/7 (DEVD), -6 (VEID), -8 (LETD), -9 (LEHD), and -10 (AEVD). FLICA kits are also available with a red or far red fluorescent label. Caspases, like most other crucial cell survival enzymes, are somewhat permissive in the target amino acid sequence they will recognize and cleave. Although FLICA reagents contain the different amino acid target sequences preferred by each caspase, they can also recognize other active caspases when they are present. ??????encourages validation of caspase activity by an orthogonal technique. FLICA can be used to label suspension or adherent cells and thin tissue sections. After labeling with FAM-FLICA, cells can be fixed or frozen. For tissues that will be paraffin-embedded after labeling, use red sulforhodamine SR-FLICA probes; do not use the green FAM-FLICA probes as the FAM dye will be quenched during the paraffin embedding process. Cells labeled with FAM-FLICA can be counter-stained with reagents such as the red live/dead stains Propidium Iodide (included in FAMFLICA kits) and 7-AAD to distinguish apoptosis from necrosis. Nuclear morphology can be concurrently observed using Hoechst 33342, a blue DNA binding dye (included in FLICA kits). Cells can be viewed directly through a fluorescence microscope (Figures 1-3,7, and 9-10), or the fluorescence intensity can be quantified using a flow cytometer (Figures 4-6) or fluorescence plate reader (Figure 8). FAM-FLICA optimally excites at 488-492 nm and has a peak emission at 515-535 nm.

Product Categories/Family for FAM-FLICA assay kit

Home/FAM-FLICA Caspase 8 Assay Kit

References

Slee, E. A., C. Adrain, and S. J. Maritin. (1999) Serial Killers: ordering caspase activation events in apoptosis. Cell Death Differ. 6:1067-1074. Earnshaw, W.C., Martins, L.M., and Kaufmann, S.H. (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Ann. Rev. Biochem. 68:383-424. Hengartner, M.O. (2000) The biochemistry of apoptosis. Nature 407:770-816. Degterev, A., Boyce, M., and Yuan, J. (2003) A decade of caspases. Oncogene 22:8543-8567. Nicholson, D.W. (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1028-1042. Thornberry, N.A., and Lazebnik, Y. (1998) Caspases: enemies within. Science 281:1312-1316. Cryns, V., and Yuan, J. (1998) Proteases to die for. Genes Dev. 12:1551 - 1570. Talanian, R.V., Quinlan, C., Trautz, S., Hackett, M.C., Mankovich, J.A., Banach, D., Ghayur, T., Brady, K.D., and Wong, W.W. (1997) Substrate specificities of caspase family proteases. J. Biol. Chem. 272:9677 - 9682. Garcia-Calvo, M., Peterson, E.P., Leiting, B., Ruel, R., Nicholson, D.W., and Thornberry, N.A. (1998) Inhibition of human caspases by peptide-based macromolecular inhibitors. J. Biol. Chem. 273:32608 - 32613. Rauber, P., Angliker, H., Walker, B., and Shaw, E. (1986) The synthesis of peptidylfluoromethanes and their properties as inhibitors of serine proteases and cysteine proteinases. Biochem. J. 239:633-640.Ekert, P.G., Silke, J., and Vaux, D.L. (1999) Caspase inhibitors. Cell Death Differ. 6:1081-1086. Bedner, E., Smolewski, P., Amstas, P., and Darzynkiewicz, Z. (2000) Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp. Cell Res. 259:308-313. Amstad, P.A., Yu, G., Johnson, G.L., Lee, B.W., Dhawan, S., and Phelps, D.J. (2001) Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors. BioTechniques 31:608-610. Smolewski, P., Bedner, E., Du, L., Hsieh, T.C., Wu, J.M., Phelps, D.J., and Darzynkiewicz, Z. (2001) Detection of caspase activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry 44:73-82.